203 related articles for article (PubMed ID: 18987961)
1. Effect of diabetes on transscleral delivery of celecoxib.
Cheruvu NP; Amrite AC; Kompella UB
Pharm Res; 2009 Feb; 26(2):404-14. PubMed ID: 18987961
[TBL] [Abstract][Full Text] [Related]
2. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
[TBL] [Abstract][Full Text] [Related]
4. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
5. Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration.
Ayalasomayajula SP; Kompella UB
Pharm Res; 2004 Oct; 21(10):1797-804. PubMed ID: 15553225
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
7. Modeling of corneal and retinal pharmacokinetics after periocular drug administration.
Amrite AC; Edelhauser HF; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):320-32. PubMed ID: 18172109
[TBL] [Abstract][Full Text] [Related]
8. Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib.
Malik P; Kadam RS; Cheruvu NP; Kompella UB
Mol Pharm; 2012 Mar; 9(3):605-14. PubMed ID: 22256989
[TBL] [Abstract][Full Text] [Related]
9. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
Thakur A; Scheinman RI; Rao VR; Kompella UB
Microvasc Res; 2011 Nov; 82(3):346-50. PubMed ID: 21945644
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
11. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
12. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).
Rao VR; Prescott E; Shelke NB; Trivedi R; Thomas P; Struble C; Gadek T; O'Neill CA; Kompella UB
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5198-204. PubMed ID: 20445119
[TBL] [Abstract][Full Text] [Related]
13. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
14. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration.
Thakkar H; Kumar Sharma R; Murthy RS
Drugs R D; 2007; 8(5):275-85. PubMed ID: 17767393
[TBL] [Abstract][Full Text] [Related]
15. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy.
Chang YH; Chen PL; Tai MC; Chen CH; Lu DW; Chen JT
Clin Exp Ophthalmol; 2006 Aug; 34(6):584-9. PubMed ID: 16925707
[TBL] [Abstract][Full Text] [Related]
16. Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats.
Wang YL; Wang K; Yu SJ; Li Q; Li N; Lin PY; Li MM; Guo JY
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):389-98. PubMed ID: 25359392
[TBL] [Abstract][Full Text] [Related]
17. Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes.
Amrite A; Pugazhenthi V; Cheruvu N; Kompella U
Expert Opin Drug Deliv; 2010 May; 7(5):631-45. PubMed ID: 20205602
[TBL] [Abstract][Full Text] [Related]
18. [The protective effect of human umbilical cord mesenchymal stem cells-induced neural stem cells in the vitreous on the blood-retinal barrier in diabetic rats].
Dong M; Zhang W; Chen S; Wang JM; Duan HT; Kong JH; Wang YX; Bi X; Song J
Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):53-58. PubMed ID: 28162200
[No Abstract] [Full Text] [Related]
19. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
20. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
